COVID-19患者经皮与开放气管造口术:纽约单中心系列比较与结局
该研究前瞻性纳入2020年4月4日至30日纽约某大型医疗中心67例COVID-19气管造口患者,比较经皮(35例)与开放(32例)两种术式的安全性和早期结局。中位随访26天,78%患者脱离机械通气,87%停用持续镇静,总并发症率16%,两种术式结局无显著差异。
要点
- COVID-19呼吸衰竭患者行气管造口可安全实施,经皮与开放术式结局无显著差异。
- 气管造口有助于脱离持续静脉镇静和机械通气。
- 总并发症率16%,以轻微出血为主。
核心结论
- 在无呼吸(apneic)条件下,经皮或开放气管造口术均可安全用于COVID-19所致呼吸衰竭患者。
- 气管造口促进了持续静脉镇静和机械通气的脱离。
研究设计与样本
- 前瞻性收集数据库的回顾性分析,纳入2020年4月4日至4月30日纽约某大型医疗中心连续67例COVID-19气管造口患者。
- 67例中男性48例、女性19例,中位年龄66岁(IQR 52-72);经皮35例,开放32例,由两名外科医生交替实施。
- 主要终点为是否需要继续机械通气;次要终点包括并发症率、镇静撤停和ICU级别护理需求。
主要发现
- 气管插管至气管造口的中位时间为23天(IQR 20-26)。
- 中位随访26天时,52例(78%)不再需要机械通气,58例(87%)停用持续镇静。
- 5例(7.5%)死于全身性原因。
- 共10例患者发生11次并发症(16%),大多数为轻微出血。
- 经皮与开放两种方法之间结局无显著差异。
临床怎么用
- 对COVID-19长期呼吸衰竭患者,可考虑在无呼吸条件下实施气管造口以促进镇静和机械通气脱离。
- 经皮与开放术式均可选择,短期结局无显著差异。
局限性
- 随访时间较短(中位26天),长期结局数据仍在继续随访中。
- 为单中心研究,样本量67例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to report the safety, efficacy, and early results of tracheostomy in patients with COVID-19 and determine whether differences exist between percutaneous and open methods. SUMMARY BACKGROUND DATA: Prolonged respiratory failure is common in symptomatic patients with COVID-19, the disease process caused by infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Tracheostomy, although posing potential risk to the operative team and other healthcare workers, may be beneficial for safe weaning of sedation and ventilator support. However, short- and long-term outcomes remain largely unknown. METHODS: A prospectively collected database of patients with COVID-19 undergoing tracheostomy at a major medical center in New York City between April 4 and April 30, 2020 was reviewed. The primary endpoint was need for continued mechanical ventilation. Secondary outcomes included complication rates, sedation weaning, and need for intensive care unit (ICU) level of care. Patient characteristics, perioperative conditions, and outcomes between percutaneous and open groups were analyzed. RESULTS: During the study period, 67 consecutive patients underwent tracheostomy, including 48 males and 19 females with a median age of 66 years [interquartile range (IQR) 52-72]. Two surgeons alternated techniques, with 35 tracheostomies performed percutaneously and 32 via an open approach. The median time from intubation to tracheostomy was 23 days (IQR 20-26). At a median follow-up of 26 days, 52 patients (78%) no longer required mechanical ventilation and 58 patients (87%) were off continuous sedation. Five patients (7.5%) died of systemic causes. There were 11 total complications (16%) in 10 patients, most of which involved minor bleeding. There were no significant differences in outcomes between percutaneous and open methods. CONCLUSIONS: Tracheostomy under apneic conditions by either percutaneous or open technique can be safely performed in patients with respiratory failure due to COVID-19. Tracheostomy facilitated weaning from continuous intravenous sedation and mechanical ventilation. Continued follow-up of these patients to ascertain long-term outcome data is ongoing.
引用
- Long SM, Chern A, Feit NZ, et al. Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City. Ann Surg. 2021. PMID: 32889885. doi:10.1097/SLA.0000000000004428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。